Abstract
We investigated the role of IL-4, IL-12 and TNF-alpha in clinically well-defined groups of Plasmodium falciparum and vivax (Pf & Pv) infected patients belonging to Group I (++), Group II (+++) and Group III (++++). On the basis of hematological parameters, hyperparasitaemia, and evidence of neurological involvement, three different levels of severity were selected attributing a score from Group I (++) to Group III (++++). In each group 16 patients each of P. falciparum and P. vivax malaria were studied. As a control group for cytokine determination 30 healthy volunteers were included in the study. Serum samples were analyzed for IL-12, IL-4 and TNF-alpha using (ELISA) obtained commercially (Ray Biotech). Hb levels of Pf and Pv patients were 8 ± 1.94, 7.6 ± 1.64 g/dl and 3.6 ± 1.23 and 10.1 ± 1.21, 9.4 ± 1.43 and 7.1 ± 0.98 g/dl. Serum iron levels of Pf and Pv patients were 85.86 ± 0.86, 81.10 ± 0.70 and 70.1 ± 0.73 and 99.47 ± 0.85, 96.67 ± 1.13 and 91.7 ± 2.65 mg/dl. TNF-alpha levels of Pf and Pv patients were 155 ± 23.66, 307.5 ± 111.87 and 955 ± 261.32 and 72 ± 9.93, 140.88 ± 23.11 and 469.37 ± 416.99 pg/ml. IL-12 levels of Pf and Pv patients were 117.5 ± 8.16, 160.63 ± 20.81 and 293.13 ± 94.64 and 75.7 ± 9.25, 112.9 ± 12.05 and 200 ± 53.78 pg/ml. IL-4 levels of Pf and Pv patients were 3.7 ± 0.11, 3.2 ± 0.13 and 2.3 ± 0.63 and 5.33 ± 1.08, 4.8 ± 0.16 and 3.9 ± 0.48 pg/ml. In the control group the values of TNF-alpha, IL-12 and IL-4 were 42.9 ± 13.5, 49.8 ± 11.59 and 6.06 ± 1.32 pg/ml respectively. Cytokines and poor oxygen delivery should not be viewed as alternative theories of malarial disease pathophysiology instead poor oxygen delivery is one of the consequences of excessive release of inflammatory cytokines which is further augmented by the present work.
Similar content being viewed by others
References
Andersson U, Wang HC, Palmblad K, Aveberger AC et al (2000) High mobility group 1 protein (HMG-1) stimulates proinflammatory cytokine synthesis in human monocytes. J Exp Med 192:565–570
Clark AI, Budd CA, Alleva ML, Cowden BW (2006) Human malarial disease. A consequence of inflammatory cytokine release. Malaria J 5:85–117
Crutcher JM, Stevenson M, Sedegah M, Hoffman SL (1995) Interleukin 12 and malaria. Res Immunol 146:552–559
Day NP, Hien TT, Schollaardt T, Loc PP et al (1999) The prognostic and pathophysiology role of pro- and anti-inflammatory cytokines in severe malaria. J Infect Dis 180:1288–1297
Gogos CA, Drosou E, Bassaris HP, Skoutelis A (2000) Pro-versus anti-inflammatory cytokine profile in patients with severe sepsis: a marker of prognosis and future therapeutic options. J Infect Dis 181:176–180
Grau GE, Taylor TE, Molyneux ME, Wirima JJ, Vassalli P, Hommel M, Lambert PH (1989) Tumor necrosis factor and diseases severity in children with falciparum malaria. N Engl J Med 320:1586–1591
Kumaratilake ML, Ferrante A, Rzepczyk MC (1990) Tumor necrosis factor enhances neutrophil-mediated killing of Plasmodium falciparum. Infect Immun 58:788–793
Luty FJA, Perkins PJ, Lell B, Ott SR et al (2000) Low interleukin 12 activity in severe Plasmodium falciparum malaria. Infect Immun 68:3909–3915
Lyke KE, Burges R, Cissoko Y et al (2004) Serum levels of the proinflammatory cytokines interleukin-1 beta (IL-1beta), IL-6, IL-8, IL-10, tumor necrosis factor alpha and IL-12 (p70) in Malian children with severe Plasmodium falciparum malaria and matched uncomplicated malaria or healthy controls. Infect Immun 72:5630–5637
Malaguarnera L, Musumeci S (2002) The immune response to Plasmodium falciparum malaria (review). Lancet Infect Dis 2:472–478
Malaguarnera L, Pignatelli S, Musumeci M, Simpore J, Musumeci S (2002) Plasma levels of interleukin-18 and interleukin-12 in Plasmodium falciparum malaria. Parasite Immunol 24:489–492
McGuire W, Hill A, Allsopp CE, Greenwood BM, Kwiatkowski D (1994) Variation in the TNF-alpha promoter region associated with susceptibility to cerebral malaria. Nature 371:508–510
Plebanski M, Hill AVS (2000) The immunology of malaria. Curr Opin Immunol 12:437–441
Riley EM (1999) Is T cell priming required for initiation of pathology in malaria infections? (review). Immunol Today 20:228–233
Tsakonask A, Tongren E, Riley E (2003) The war between the malaria parasites and the immune system: immunity immunoregulation and immunopathology. Clin Exp Immunol 133:145–152
White NJ, Breman JG (2001) Malaria and babesiosis: diseases caused by red blood cell parasites. In: Braunwald E (ed) Harrison’s principles of internal medicine. McGraw-Hill, New York, pp 1203–1213
Winkler S, Willheim M, Baier K, Schmid D, Aichelburg A, Graninger W, Kremsner PG (1998) Reciprocal regulation of Th1 and Th2-cytokine-producing T cells during clearance of parasitemia in Plasmodium falciparum malaria. Infect Immun 66:6040–6044
Acknowledgments
ANS, AKS, PCM and RKD conceived the study; ANS and PCM designed the study protocol, ANS and RKD carried out the clinical assessment. ANS and AKS carried out the immunoassays and cytokine determination, and analysis and interpretation of these data. ANS, AKS and PCM drafted the manuscript. ANS, AKS, PCM and RKD critically revised the manuscript for intellectual content. All authors read and approved the final manuscript. ANS and PCM are guarantors of the paper.
Funding
None.
Conflict of interest
None.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Sarangi, A., Mohapatra, P.C., Dalai, R.K. et al. Serum IL-4, IL-12 and TNF-alpha in malaria: a comparative study associating cytokine responses with severity of disease from the Coastal Districts of Odisha. J Parasit Dis 38, 143–147 (2014). https://doi.org/10.1007/s12639-013-0237-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12639-013-0237-1